The National Center for Oncological Hadrontherapy (CNAO) in Pavia has launched a new rotating-beam proton therapy system manufactured by Hitachi. Treatments began in October, marking 15 years since the center treated its first patient in 2011. Over this period, CNAO has treated more than 6,400 patients, including over 300 children, using both protons and carbon ions. This makes the facility one of only eight multi-particle centers globally. The new system features a compact synchrotron and a high-precision gantry that allows the proton beam to rotate 360 degrees around the patient. This technology aims to improve treatment precision, spare healthy tissue, reduce session duration, and increase annual capacity by over 200 patients.
Bias read (Center): The article focuses exclusively on medical advancements and institutional milestones without referencing political actors, policies, or controversies, resulting in a neutral informational tone.





